Pubblicazioni

CML-466 Asciminib Provides Durable Molecular Responses in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) With the T315I Mutation: Updated Efficacy and Safety Data From a Phase I Trial

2022 - CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

Hughes, Timothy P.; Cortes, Jorge E.; RÃ©a, Delphine; Mauro, Michael J.; Hochhaus, Andreas; Kim, Dong-Wook; Sasaki, Koji; Lang, Fabian; Heinrich, Michael C.; Breccia, Massimo; Deininger, Michael; Goh, Yeow-Tee; Janssen, Jeroen J. W. M; Talpaz, Moshe; Coutre, Philipp le; Kapoor, Shruti; Cacciatore, Silvia; Polydoros, Fotis; Agrawal, Nithya; Mahon, Francois-Xavier

Relationship Between High Body Mass Index (BMI) and Treatment Outcomes in Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated with Dasatinib or Imatinib: Retrospective Analysis of the Phase 3 DASISION Trial

2020 - CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

Breccia, Massimo; Cortes Jorge, E.; Shah Neil, P.; Saglio, Giuseppe; Jimenez-Velasco, Antonio; Le Coutre, Philipp; Brun, Alexander; Degutis, Irene; Bathena, Sai; Sy, Oumar; Jabbour, Elias

Efficacy and Safety of Asciminib in Heavily Pretreated Patients with Philadelphia Chromosome-Positive (Ph plus ) Chronic Myeloid Leukemia in Chronic Phase (CML-CP) with Sensitivity to Tyrosine Kinase Inhibitors (TKIs)

2020 - CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

Hughes, Timothy; Mauro, Michael; Kim, Dong-Wook; Cortes, Jorge; Rea, Delphine; Minami, Hironobu; Breccia, Massimo; Deangelo, Daniel; Hochhaus, Andreas; Goh, Yeow-Tee; le Coutre, Philipp; Lang, Fabian; Cacciatore, Silvia; Aimone, Paola; Stenson, Laura; Polydoros, Fotis; Talpaz, Moshe